These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 35883650)

  • 21. Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.
    Liu T; Luo H; Zhang J; Hu X; Zhang J
    BMC Cancer; 2021 Jul; 21(1):783. PubMed ID: 34229636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression Pattern and Prognostic Analysis of Branched-Chain Amino Acid Catabolism-Related Genes in Non-Small Cell Lung Cancer.
    Yao X; Deng Y; Zhou J; Jiang L; Song Y
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):107. PubMed ID: 37395022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a prognostic model for non-small-cell lung cancer based on ferroptosis-related genes.
    Han K; Wang J; Qian K; Zhao T; Liu X; Zhang Y
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma.
    Fang X; Liu X; Weng C; Wu Y; Li B; Mao H; Guan M; Lu L; Liu G
    Int J Med Sci; 2020; 17(17):2718-2727. PubMed ID: 33162799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
    Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
    BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and Validation of a Ferroptosis-Related Gene Signature to Predict Overall Survival in Lung Adenocarcinoma.
    Wang S; Xie Z; Wu Z
    Front Genet; 2021; 12():793636. PubMed ID: 35096011
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas.
    Mao K; Tang R; Wu Y; Zhang Z; Gao Y; Huang H
    Front Genet; 2023; 14():1118273. PubMed ID: 36923797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferroptosis-Related Gene GCLC Is a Novel Prognostic Molecular and Correlates with Immune Infiltrates in Lung Adenocarcinoma.
    Luo L; Zhang Z; Weng Y; Zeng J
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
    Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
    BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and validation of a robust ferroptosis-associated gene signature predictive of prognosis in lung adenocarcinoma.
    Zhou M; Zhu X
    Medicine (Baltimore); 2022 Apr; 101(16):e29068. PubMed ID: 35482981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma.
    Wang Y; Chen W; Zhu M; Xian L
    Front Mol Biosci; 2021; 8():692530. PubMed ID: 34395526
    [No Abstract]   [Full Text] [Related]  

  • 33. Dissecting the ferroptosis-related prognostic biomarker and immune microenvironment of driver gene-negative lung cancer.
    Zhou R; Ma HC; Liu YH; Chen X; Chang XS; Chen YD; Liu LR; Li Y; Zhu YJ; Zhang HB
    Exp Biol Med (Maywood); 2022 Aug; 247(16):1447-1465. PubMed ID: 35762414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
    Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
    BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
    Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
    Front Immunol; 2022; 13():950001. PubMed ID: 36091041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FKBP3, a poor prognostic indicator, promotes the progression of LUAD via regulating ferroptosis and immune infiltration.
    Li S; Yang L; Li J
    Medicine (Baltimore); 2024 Jun; 103(26):e38606. PubMed ID: 38941396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
    Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a ferroptosis-based model to predict prognosis, tumor microenvironment, and drug response for lung adenocarcinoma with weighted genes co-expression network analysis.
    Cheng T; Shan G; Yang H; Gu J; Lu C; Xu F; Ge D
    Front Pharmacol; 2022; 13():1072589. PubMed ID: 36467089
    [No Abstract]   [Full Text] [Related]  

  • 40. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
    Hou G; Lu Z; Bi Y; Deng J; Yang X
    Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.